Business Description
Kobayashi Pharmaceutical Co Ltd
ISIN : JP3301100008
Share Class Description:
TSE:4967: Ordinary SharesTotal Employee Number:
4,146Description
Kobayashi Pharmaceutical Co Ltd is engaged in the manufacture and sale of healthcare products, daily necessities, and body warmers. The company operates through two reportable segments: Domestic Business and International Business, which handle production and sales activities in Japan and overseas, respectively. The company's product portfolio includes disposable body warmers, cooling gel sheets, OTC pharmaceuticals, oral hygiene products, air fresheners, eyeglass wipes, and deodorizing/household sundries.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 89.45 | |||||
Equity-to-Asset | 0.82 | |||||
Debt-to-EBITDA | 0.06 | |||||
Interest Coverage | 490.86 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 5.9 | |||||
Beneish M-Score | -2.89 | |||||
WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 1.1 | |||||
3-Year EBITDA Growth Rate | -27 | |||||
3-Year EPS without NRI Growth Rate | -5.3 | |||||
3-Year FCF Growth Rate | -8.5 | |||||
3-Year Book Growth Rate | 2.9 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 62.42 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 4.09 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 33.45 | |||||
9-Day RSI | 42.49 | |||||
14-Day RSI | 44.8 | |||||
3-1 Month Momentum % | -9.28 | |||||
6-1 Month Momentum % | -2.66 | |||||
12-1 Month Momentum % | 2.32 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 3.04 | |||||
Quick Ratio | 2.41 | |||||
Cash Ratio | 1.55 | |||||
Days Inventory | 123.79 | |||||
Days Sales Outstanding | 83.85 | |||||
Days Payable | 38.41 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 1.9 | |||||
Dividend Payout Ratio | 0.5 | |||||
3-Year Dividend Growth Rate | 4.9 | |||||
Forward Dividend Yield % | 1.92 | |||||
5-Year Yield-on-Cost % | 2.66 | |||||
3-Year Average Share Buyback Ratio | 0.7 | |||||
Shareholder Yield % | 1.96 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 51.24 | |||||
Operating Margin % | 8.24 | |||||
Net Margin % | 1.84 | |||||
EBITDA Margin % | 7.5 | |||||
FCF Margin % | 6.94 | |||||
OCF Margin % | 15.34 | |||||
ROE % | 1.46 | |||||
ROA % | 1.18 | |||||
ROIC % | 6.79 | |||||
3-Year ROIIC % | -9.93 | |||||
ROC (Joel Greenblatt) % | 4.02 | |||||
ROCE % | 1.75 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 133.16 | |||||
Forward PE Ratio | 39.05 | |||||
PE Ratio without NRI | 26.5 | |||||
Shiller PE Ratio | 23.92 | |||||
PS Ratio | 2.45 | |||||
PB Ratio | 1.96 | |||||
Price-to-Tangible-Book | 2.13 | |||||
Price-to-Free-Cash-Flow | 35.29 | |||||
Price-to-Operating-Cash-Flow | 15.97 | |||||
EV-to-EBIT | 91.44 | |||||
EV-to-EBITDA | 27.52 | |||||
EV-to-Revenue | 2.07 | |||||
EV-to-FCF | 29.93 | |||||
Price-to-GF-Value | 0.95 | |||||
Price-to-Projected-FCF | 1.55 | |||||
Price-to-Median-PS-Value | 0.67 | |||||
Price-to-Graham-Number | 1.58 | |||||
| Price-to-Net-Current-Asset-Value | 5.01 | |||||
| Price-to-Net-Cash | 21.42 | |||||
Earnings Yield (Greenblatt) % | 1.1 | |||||
FCF Yield % | 2.84 | |||||
Forward Rate of Return (Yacktman) % | -11.79 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Kobayashi Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil 円) | 166,800 | ||
| EPS (TTM) (円) | 41.28 | ||
| Beta | -0.0543 | ||
| 3-Year Sharpe Ratio | -0.49 | ||
| 3-Year Sortino Ratio | -0.66 | ||
| Volatility % | 13 | ||
| 14-Day RSI | 44.8 | ||
| 14-Day ATR (円) | 101.268567 | ||
| 20-Day SMA (円) | 5545.9 | ||
| 12-1 Month Momentum % | 2.32 | ||
| 52-Week Range (円) | 5030 - 6140 | ||
| Shares Outstanding (Mil) | 74.34 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Kobayashi Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Kobayashi Pharmaceutical Co Ltd Stock Events
| Event | Date | Price (円) | ||
|---|---|---|---|---|
| JPY 61.000000 Cash Dividend | 2026-12-29 | In 160 days | ||
| Third quarter earnings results for 2026 | 2026-11-11 | In 112 days | ||
| Second quarter earnings results for 2026 | 2026-08-05 | In 14 days | ||
| JPY 45.000000 Cash Dividend | 2026-06-29 | 5,580.00 (+0.29%) | ||
| First quarter earnings conference call for 2026 | 2026-05-08 | 5,821.00 (+0.36%) | ||
| First quarter earnings results for 2026 | 2026-05-08 | 5,821.00 (+0.36%) | ||
| General meeting for 2025 | 2026-03-27 10:00 | 5,751.00 (+0.17%) | ||
| Annual report for 2025 | 2026-03-25 | 5,693.00 (+0.78%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-02-10 | 5,320.00 (-0.39%) | ||
| Fourth quarter earnings results for 2025 | 2026-02-10 | 5,320.00 (-0.39%) |
Show
Entries
Kobayashi Pharmaceutical Co Ltd Frequently Asked Questions
What is Kobayashi Pharmaceutical Co Ltd(TSE:4967)'s stock price today?
The current price of TSE:4967 is 円5497.00. The 52 week high of TSE:4967 is 円6140.00 and 52 week low is 円5030.00.
When is next earnings date of Kobayashi Pharmaceutical Co Ltd(TSE:4967)?
The next earnings date of Kobayashi Pharmaceutical Co Ltd(TSE:4967) is 2026-08-05 Est..
Does Kobayashi Pharmaceutical Co Ltd(TSE:4967) pay dividends? If so, how much?
The Dividend Yield %  of Kobayashi Pharmaceutical Co Ltd(TSE:4967) is 1.9% (As of Today), Highest Dividend Payout Ratio of Kobayashi Pharmaceutical Co Ltd(TSE:4967) was 0.5. The lowest was 0.27. And the median was 0.31. The  Forward Dividend Yield % of Kobayashi Pharmaceutical Co Ltd(TSE:4967) is 1.92%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Kobayashi Pharmaceutical Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers